BRIEF published on 07/08/2024 at 16:20, 2 years 3 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million Acquisition Investment Biotech Immuno-oncology QARZIBA®
BRIEF published on 07/08/2024 at 16:20, 2 years 3 months ago APEIRON Biologics va être acquis par Ligand Pharmaceuticals pour 100 millions de dollars Acquisition Investissement Immuno-oncologie Biotechnologies QARZIBA®
PRESS RELEASE published on 07/08/2024 at 16:15, 2 years 3 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
Published on 10/23/2026 at 13:23, 2 hours 36 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 2 hours 59 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 2 hours 59 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 13 hours 39 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 16 hours 29 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/23/2026 at 15:40, 19 minutes ago Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 15:24, 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/23/2026 at 07:00, 8 hours 59 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 21 hours 59 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 21 hours 59 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 21 hours 59 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
